Applied Genetic Technologies Corp (AGTC) SEC Filing 8-K Material Event for the period ending Friday, February 25, 2022

Applied Genetic Technologies Corp

CIK: 1273636 Ticker: AGTC

View differences made from one to another to evaluate Applied Genetic Technologies Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Applied Genetic Technologies Corp.


Assess how Applied Genetic Technologies Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Applied Genetic Technologies Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: AGTC
CIK: 1273636
Form Type: 8-K Corporate News
Accession Number: 0001193125-22-062997
Submitted to the SEC: Wed Mar 02 2022 4:18:44 PM EST
Accepted by the SEC: Wed Mar 02 2022
Period: Friday, February 25, 2022
Industry: Biological Products No Disgnostic Substances
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: